Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
27.96
+0.81 (2.98%)
At close: Apr 8, 2026
39.24% (1Y)
| Market Cap | 11.84B +28.4% |
| Revenue (ttm) | 674.49M -10.3% |
| Net Income | 23.29M -82.7% |
| EPS | 0.05 -83.0% |
| Shares Out | 423.51M |
| PE Ratio | 508.44 |
| Forward PE | n/a |
| Dividend | 0.20 (0.74%) |
| Ex-Dividend Date | May 27, 2025 |
| Volume | 4,882,500 |
| Average Volume | 4,669,151 |
| Open | 27.68 |
| Previous Close | 27.15 |
| Day's Range | 27.30 - 28.28 |
| 52-Week Range | 16.73 - 42.26 |
| Beta | 0.34 |
| RSI | 46.65 |
| Earnings Date | Apr 28, 2026 |